Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1149.5
(9.3%)
INR 1149.5
(9.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.51 Billion INR | -19.88% |
| 2022 | 13.12 Billion INR | 1.74% |
| 2021 | 12.89 Billion INR | 31.62% |
| 2020 | 9.79 Billion INR | 21.15% |
| 2019 | 8.08 Billion INR | 120.84% |
| 2018 | 3.66 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.3 Billion INR | -8.79% |
| 2023 Q2 | 2.31 Billion INR | -33.52% |
| 2023 Q4 | 2.52 Billion INR | 15.06% |
| 2023 FY | 10.51 Billion INR | -19.88% |
| 2023 Q3 | 2.19 Billion INR | -4.86% |
| 2023 Q1 | 3.47 Billion INR | 1.83% |
| 2022 Q3 | 3.53 Billion INR | 27.07% |
| 2022 Q1 | 3.38 Billion INR | 1.61% |
| 2022 FY | 13.12 Billion INR | 1.74% |
| 2022 Q4 | 3.41 Billion INR | -3.52% |
| 2022 Q2 | 2.78 Billion INR | -17.83% |
| 2021 Q1 | 2.63 Billion INR | 15.01% |
| 2021 FY | 12.89 Billion INR | 31.62% |
| 2021 Q4 | 3.33 Billion INR | -14.85% |
| 2021 Q3 | 3.91 Billion INR | 30.1% |
| 2021 Q2 | 3 Billion INR | 14.1% |
| 2020 Q4 | 2.29 Billion INR | -16.57% |
| 2020 Q3 | 2.74 Billion INR | 15.82% |
| 2020 Q2 | 2.37 Billion INR | -0.35% |
| 2020 FY | 9.79 Billion INR | 21.15% |
| 2020 Q1 | 2.38 Billion INR | 50.86% |
| 2019 Q2 | 2.72 Billion INR | 38.27% |
| 2019 FY | 8.08 Billion INR | 120.84% |
| 2019 Q3 | 1.78 Billion INR | -34.52% |
| 2019 Q4 | 1.57 Billion INR | -11.63% |
| 2019 Q1 | 1.97 Billion INR | -17.53% |
| 2018 Q4 | 2.39 Billion INR | 88.58% |
| 2018 Q3 | 1.26 Billion INR | 0.0% |
| 2018 FY | 3.66 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 97.832% |
| NATCO Pharma Limited | 40.02 Billion INR | 73.729% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -305.546% |
| Achyut Healthcare Limited | 61.36 Million INR | -17031.674% |
| Ajanta Pharma Limited | 42.08 Billion INR | 75.02% |
| Alkem Laboratories Limited | 126.67 Billion INR | 91.7% |
| Alpa Laboratories Limited | 1.08 Billion INR | -866.86% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 82.799% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 18.848% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 96.337% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -122.077% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -36.496% |
| Brooks Laboratories Limited | 794.86 Million INR | -1222.689% |
| Divi's Laboratories Limited | 78.45 Billion INR | 86.598% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 96.234% |
| Eris Lifesciences Limited | 20.09 Billion INR | 47.672% |
| FDC Limited | 19.42 Billion INR | 45.889% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 91.1% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 53.953% |
| Granules India Limited | 45.06 Billion INR | 76.67% |
| Gufic Biosciences Limited | 8.06 Billion INR | -30.333% |
| Hester Biosciences Limited | 3.04 Billion INR | -245.22% |
| Indoco Remedies Limited | 17.89 Billion INR | 41.247% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 17.921% |
| Ipca Laboratories Limited | 76.22 Billion INR | 86.207% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -403.758% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -1985.13% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -907.671% |
| Laurus Labs Limited | 50.01 Billion INR | 78.98% |
| Lupin Limited | 200.1 Billion INR | 94.746% |
| Mankind Pharma Limited | 103.34 Billion INR | 89.827% |
| Medicamen Biotech Limited | 1.79 Billion INR | -486.345% |
| Medico Remedies Limited | 1.44 Billion INR | -625.468% |
| Megasoft Limited | 373.95 Million INR | -2711.459% |
| Piramal Pharma Limited | 81.71 Billion INR | 87.133% |
| RPG Life Sciences Limited | 5.82 Billion INR | -80.629% |
| Sigachi Industries Limited | 3.98 Billion INR | -163.526% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -1291.686% |
| Unichem Laboratories Limited | 16.57 Billion INR | 36.567% |
| Wanbury Limited | 5.75 Billion INR | -82.638% |
| Windlas Biotech Limited | 6.3 Billion INR | -66.629% |
| ZIM Laboratories Limited | 3.67 Billion INR | -186.142% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 94.473% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 8.678% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -149.591% |
| Bal Pharma Limited | 3.39 Billion INR | -209.933% |
| Strides Pharma Science Limited | 40.51 Billion INR | 74.048% |
| Venus Remedies Limited | 5.91 Billion INR | -77.759% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 42.09% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 37.571% |
| Shilpa Medicare Limited | 11.51 Billion INR | 8.705% |
| Aarti Drugs Limited | 25.28 Billion INR | 58.421% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 50.384% |
| Suven Life Sciences Limited | 116.92 Million INR | -8891.385% |
| Ind-Swift Limited | 5.02 Billion INR | -109.238% |
| Valiant Laboratories Limited | 1.82 Billion INR | -477.485% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 69.825% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 15.103% |
| Themis Medicare Limited | 3.81 Billion INR | -175.396% |
| Hikal Limited | 17.84 Billion INR | 41.087% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 90.087% |
| Sequent Scientific Limited | 13.69 Billion INR | 23.244% |
| Novartis India Limited | 3.35 Billion INR | -213.771% |
| Wockhardt Limited | 27.89 Billion INR | 62.304% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 84.315% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -2526.067% |
| Neuland Laboratories Limited | 15.58 Billion INR | 32.544% |
| Morepen Laboratories Limited | 17.01 Billion INR | 38.225% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -581.05% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -185.233% |